High blood sugar levels can damage all parts of your body. In this post, we’ll guide you through all the parts of your body, head to toe that
AstraZeneca reported positive phase 3 trial results of Brilinta (ticagrelor) plus aspirin, which reduced the relative risk of cardiovascular events
Total deaths from heart disease, stroke, diabetes and hypertension – known collectively as cardiometabolic disease – have been increasing
Exercise. Improve your diet. Lose weight. You’ve probably heard the mantra over and over again. People living with diabetes know that along
As many with diabetes know, having the condition is a risk factor for many other cardiovascular health conditions, one of them is a stroke.
Researchers in New Zealand have discovered that high-intensity exercise can reduce or reverse the loss in heart function caused by Type 2 diabetes.
A new landmark clinical trial from Standford Medicine shows that a drug lowers the risk of kidney failure by a third in people with Type 2 diabetes
People under age 40 who are diagnosed with Type 2 diabetes are more likely to have or die from cardiovascular disease than those of similar age
Researchers with the VA San Diego Healthcare System and the University of California San Diego have shown that a gene transfer technique can combat
AstraZeneca’s drug Brilinta® met primary endpoints in Phase 3 trials, the company reported on Monday. The trials showed that Brilinta
Get a little dLife delivered to your inbox every week.
Leave this field empty if you’re human: